BioMedWire Stocks Archives - Page 11 of 79

FridayAug 22, 2025 10:00 am

Pioneering Therapy Could Slow the Effects of Aging

A new groundbreaking therapy could slow down or even reverse aging by recharging body cells with new “batteries” that provide new energy for bodily function. The new therapy utilizes mitochondria from the placenta of infants, which are then transplanted into older people or those suffering from diseases that are currently regarded as incurable. Minovia Therapeutics, a company based in Israel, is the first firm globally to test mitochondria transplantation in human beings as a way to help people remain younger for a longer time and also treat conditions that are regarded as incurable. Mitochondria are tiny organelles within cells, and…

ThursdayAug 21, 2025 10:00 am

Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors

Scientists at Columbia University have engineered a cancer treatment that leverages bacteria to smuggle cancer-killing viruses into tumors in a method that sidesteps the defenses of the immune system. This groundbreaking approach utilizes two vital weapons against the cancer; the bacteria are drawn to cancer cells, and the viruses inside the bacteria deliver the killer blow to the tumor cells after being delivered there by the bacteria. The study team was successful in creating built-in safeguards intended to prevent the viruses from infiltrating and infecting tissues outside the tumor environment. Their research promises to introduce a new paradigm in the…

TuesdayAug 19, 2025 10:00 am

Young Americans Face Health Insurance Chaos as They Turn 26

As young Americans turn 26, they are faced with a major transition that requires them to find their own health insurance since they no longer qualify to remain on the health insurance plan of their family. As many have found out at this transition point, getting your own insurance is a maze with many twists and turns that can leave one baffled and helpless. How did this transition come about? Back in 2010, the Affordable Care Act was passed and signed into law. This law guaranteed that young people would be assured of having health insurance until they reached the…

FridayAug 15, 2025 10:00 am

Study Finds That Low BSA Psoriasis Could Have a High Disease Burden

For decades, the severity of psoriasis has been classified on the basis of thresholds reflecting the BSA, or body surface area, impacted by the condition. Under this classification, individuals with less than 3 percent of BSA were categorized as having mild psoriasis; those with a BSA ranging between 3 and 10 percent were regarded as having moderate psoriasis; while those with a BSA in excess of 10 percent were classified as having severe psoriasis. This way of classifying psoriasis influences the prescription of systemic therapies, particularly biologics indicated for psoriasis. Many insurance firms require that a patient has a BSA…

ThursdayAug 14, 2025 10:00 am

What Women Need to Know About Benign Brain Tumors

It is easy to shrug off forgetfulness or a headache as stress. However, this isn’t always the case as those symptoms could point to the possibility of a tumor in the brain. For women, this risk is even higher given that women make up 62.9% of people who develop noncancerous brain tumors. It is therefore important to know what to look out for, and which steps to take. First, it is important to know that when you are found to have a “benign” tumor in your brain, it doesn’t mean that you are fine. The word benign is used as…

TuesdayAug 12, 2025 10:00 am

Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option

For long, researchers have posited that a link between our brain and gut contributes to the onset of Parkinson’s disease. Now a new study suggests that B-vitamin supplements could address some of the medical needs of Parkinson’s disease patients after their research linked specific vitamin deficiencies to the disease. Researchers at Nagoya University in Japan, led by Hiroshi Nishiwaki, who conducted the study, suggest that using supplements containing biotin and riboflavin could help in slowing PD progression or at least providing symptomatic relief to patients. Currently, PD doesn’t have a known cure despite approximately 10 million individuals living with the…

FridayAug 08, 2025 10:00 am

Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells

Researchers in China have discovered a way to supercharge the treatment of lung cancer by transplanting mitochondria into the tumor environment. This transplantation increases the effectiveness of chemotherapy while boosting the immune system’s ability to fight the cancer. The team combined cisplatin (a lung cancer chemo drug) with mitochondrial transplantation. Chemotherapy has always been a major part of treating lung cancer. However, this therapy usually compromises immune system function, thereby making long-term cancer suppression challenging since the immune system becomes weak and can’t control the progression of the cancer. By using the new approach, researchers were able to boost immune…

ThursdayAug 07, 2025 10:00 am

How to Rebuild Trust in the US Healthcare System

A recent survey undertaken by Gallup in 2025 found that since 2021, there has been a 14% drop in the level of the public’s trust in the physicians who take care of them. This decline was the steepest among the declines registered by all the professions focused on. Today, most people are relying on health advice from family members, their peers, social media and other online communities. This isn’t the way things should be. Physicians and other healthcare professionals ought to be the go-to professionals for healthcare advice. How can this loss of trust in physicians be restored? First, it…

TuesdayAug 05, 2025 10:00 am

Study Finds That Inflammation Markers in Diabetics Influence Depression Treatment Outcomes

On average, diabetics tend to suffer from depression at higher rates than is seen in the general population. A new study conducted by a team at the German Diabetes Center and other institutions in Germany has found that the markers of chronic inflammation influence how successful the treatments provided for depression will be for patients living with diabetes. The study found that there are significant differences between the chronic inflammation biomarkers in people with Type 1 diabetes and those in people with Type 2 diabetes. The findings of this research could help to personalize the ways in which depression is…

FridayAug 01, 2025 10:00 am

Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment

Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams could rely on to predict which patients having glioblastoma stand higher chances of benefiting from bevacizumab, a cancer drug. The study, whose findings were published in the journal JCO Precision Oncology, found that patients who had a genetic alteration referred to as CDK4 and were treated using bevacizumab tended to have longer survival times when compared to patients that underwent the same treatment but didn’t have this genetic change. This finding suggests that conducting tests to identify this particular genetic change could help medical teams…